Format

Send to

Choose Destination
See comment in PubMed Commons below
PLoS Med. 2010 Mar 2;7(3):e1000224. doi: 10.1371/journal.pmed.1000224.

Where will the next generation of stroke treatments come from?

Author information

1
National Stroke Research Institute, Florey Neuroscience Institutes, University of Melbourne, Austin Health, Victoria, Australia.

Abstract

Remarkable progress has occurred over the last two decades in stroke interventions. Many have been developed on the basis of their efficacy in other disorders. This "inheritance" approach should continue, but two areas where completely novel therapeutic targets might emerge are the stimulation of neuroplasticity and unraveling the genetic code of stroke heterogeneity (Table 2). For the former, the next steps are to identify small-molecule, nontoxic compounds that most effectively enhance plasticity in animal models, and then subject them to clinical trial in humans. For the latter, more and larger-scale cooperative GWASs in carefully phenotyped stroke populations are required to better understand the polygenic nature of cerebrovascular disease. Then, the physiological relevance of genetic abnormalities can be determined in in vitro and in vivo systems before candidate compounds are developed.

PMID:
20208999
PMCID:
PMC2830448
DOI:
10.1371/journal.pmed.1000224
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Public Library of Science Icon for PubMed Central
    Loading ...
    Support Center